1,4-Dioxaspiro[4.5]decan-8-ylhydrazine dihydrochloride, 98%, 500mg

Ethyl 1-benzyl-3-oxo-piperidine-4-carboxylate, 95.0%, 5g

3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

(E)-2-Methyl-5-(2-nitrovinyl)thiazole, 98%, 500mg

4-BROMO-5-METHOXY-1H-INDAZOLE, 95%, 10g

((2R,6R)-4-benzyl-6-methylmorpholin-2-yl)methanol, 95%, 1g

tert-Butyl (1R,2S,3S,5S)-3-amino-2-fluoro-8-azabicyclo[3.2.1]octane-8-carboxylate, 98%, 500mg

(S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate, 95.0%, 250mg

3-(METHOXYMETHOXY)PROPANENITRILE, 95.0%, 1g

4-Bromo-1-methyl-1H-pyrazol-3-amine, 95.0%, 25g

Methyl 2-amino-5-chloro-3-methylbenzoate, 95%, 250mg

HPLC column NUCLEODUR® C8 Gravity 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

Aluminum chloride, min. 99%, anhydrous, sublimated, 1 kg, glass packaging